Since a changed growth factor secretion by the RPE is thought to play a role in the induction of various eye diseases involving cell proliferation, voltage-dependent Ca2+ channels or their regulatory proteins could be included as targets in therapeutic strategies acting directly at the secretion site of angiogenic factors. Here, CA2 is linked to eye disorder.